Altele
acum 19 ore
Eli Lilly has secured approval in the United States for its new weight-loss drug, available in pill form. This marks a significant advancement in the treatment of obesity and related health conditions.
Altele
acum 1 zi
Eli Lilly is set to acquire Centessa Therapeutics for $7.8 billion, bolstering its drug development pipeline. The acquisition provides Eli Lilly with access to Centessa's portfolio of promising drug candidates.
Sanatate
acum 17 ore
Administratia americana a aprobat un nou medicament oral dezvoltat de Eli Lilly pentru pierderea in greutate.